Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals
07 Dec 2023 //
PR NEWSWIRE
Vyera and PhoenixusSign Agreement to Sell Rights to Daraprim and Vecamyl
01 Aug 2023 //
PR NEWSWIRE
Shkreli`s former company Vyera files for bankruptcy
11 May 2023 //
FIERCE PHARMA
Pharma Bro’ Shkreli Fails to Lift Industry Ban During Appeal
27 Apr 2022 //
BLOOMBERG
Vyera has settled with FTC for $40M as Shkreli`s trial looms
08 Dec 2021 //
FIERCEPHARMA
Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes
11 Sep 2021 //
ENDPTS
New York lawsuit again accuses Martin Shkreli of manipulation from behind bars
10 Dec 2020 //
ENDPTS